Eintrag weiter verarbeiten
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc)
Gespeichert in:
| Zeitschriftentitel: | Annals of Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Annals of Oncology, 25, 2014, S. iv514 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Spigel, D.R. Weaver, R.W. McCleod, M. Hamid, O. Stille, J.R. Polzer, J. Roberson, S. Salgia, R. Spigel, D.R. Weaver, R.W. McCleod, M. Hamid, O. Stille, J.R. Polzer, J. Roberson, S. Salgia, R. |
|---|---|
| author |
Spigel, D.R. Weaver, R.W. McCleod, M. Hamid, O. Stille, J.R. Polzer, J. Roberson, S. Salgia, R. |
| spellingShingle |
Spigel, D.R. Weaver, R.W. McCleod, M. Hamid, O. Stille, J.R. Polzer, J. Roberson, S. Salgia, R. Annals of Oncology Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) Oncology Hematology |
| author_sort |
spigel, d.r. |
| spelling |
Spigel, D.R. Weaver, R.W. McCleod, M. Hamid, O. Stille, J.R. Polzer, J. Roberson, S. Salgia, R. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdu355.10 Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) Annals of Oncology |
| doi_str_mv |
10.1093/annonc/mdu355.10 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR1MzU1LjEw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR1MzU1LjEw |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Elsevier BV, 2014 |
| imprint_str_mv |
Elsevier BV, 2014 |
| issn |
0923-7534 |
| issn_str_mv |
0923-7534 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
spigel2014phaseiistudyofcarboplatinetoposideplusly2510924acxcr4peptideantagonistversuscarboplatinetoposideinpatientswithextensivestagesmallcelllungcancersclc |
| publishDateSort |
2014 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Annals of Oncology |
| source_id |
49 |
| title |
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_unstemmed |
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_full |
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_fullStr |
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_full_unstemmed |
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_short |
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_sort |
phase ii study of carboplatin/etoposide plus ly2510924, a cxcr4 peptide antagonist, versus carboplatin/etoposide in patients with extensive-stage small cell lung cancer (sclc) |
| topic |
Oncology Hematology |
| url |
http://dx.doi.org/10.1093/annonc/mdu355.10 |
| publishDate |
2014 |
| physical |
iv514 |
| description |
|
| container_start_page |
0 |
| container_title |
Annals of Oncology |
| container_volume |
25 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792327954278121489 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:45:36.173Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Phase+Ii+Study+of+Carboplatin%2FEtoposide+Plus+Ly2510924%2C+a+Cxcr4+Peptide+Antagonist%2C+Versus+Carboplatin%2FEtoposide+in+Patients+with+Extensive-Stage+Small+Cell+Lung+Cancer+%28Sclc%29&rft.date=2014-09-01&genre=article&issn=0923-7534&volume=25&pages=iv514&jtitle=Annals+of+Oncology&atitle=Phase+Ii+Study+of+Carboplatin%2FEtoposide+Plus+Ly2510924%2C+a+Cxcr4+Peptide+Antagonist%2C+Versus+Carboplatin%2FEtoposide+in+Patients+with+Extensive-Stage+Small+Cell+Lung+Cancer+%28Sclc%29&aulast=Salgia&aufirst=R.&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdu355.10&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792327954278121489 |
| author | Spigel, D.R., Weaver, R.W., McCleod, M., Hamid, O., Stille, J.R., Polzer, J., Roberson, S., Salgia, R. |
| author_facet | Spigel, D.R., Weaver, R.W., McCleod, M., Hamid, O., Stille, J.R., Polzer, J., Roberson, S., Salgia, R., Spigel, D.R., Weaver, R.W., McCleod, M., Hamid, O., Stille, J.R., Polzer, J., Roberson, S., Salgia, R. |
| author_sort | spigel, d.r. |
| container_start_page | 0 |
| container_title | Annals of Oncology |
| container_volume | 25 |
| description | |
| doi_str_mv | 10.1093/annonc/mdu355.10 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR1MzU1LjEw |
| imprint | Elsevier BV, 2014 |
| imprint_str_mv | Elsevier BV, 2014 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0923-7534 |
| issn_str_mv | 0923-7534 |
| language | English |
| last_indexed | 2024-03-01T12:45:36.173Z |
| match_str | spigel2014phaseiistudyofcarboplatinetoposideplusly2510924acxcr4peptideantagonistversuscarboplatinetoposideinpatientswithextensivestagesmallcelllungcancersclc |
| mega_collection | Elsevier BV (CrossRef) |
| physical | iv514 |
| publishDate | 2014 |
| publishDateSort | 2014 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Annals of Oncology |
| source_id | 49 |
| spelling | Spigel, D.R. Weaver, R.W. McCleod, M. Hamid, O. Stille, J.R. Polzer, J. Roberson, S. Salgia, R. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdu355.10 Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) Annals of Oncology |
| spellingShingle | Spigel, D.R., Weaver, R.W., McCleod, M., Hamid, O., Stille, J.R., Polzer, J., Roberson, S., Salgia, R., Annals of Oncology, Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc), Oncology, Hematology |
| title | Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_full | Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_fullStr | Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_full_unstemmed | Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_short | Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| title_sort | phase ii study of carboplatin/etoposide plus ly2510924, a cxcr4 peptide antagonist, versus carboplatin/etoposide in patients with extensive-stage small cell lung cancer (sclc) |
| title_unstemmed | Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) |
| topic | Oncology, Hematology |
| url | http://dx.doi.org/10.1093/annonc/mdu355.10 |